have identified an oncogenic gene lnc-RP11-536 K7.3, which enhanced the glycolysis and chemoresistance to oxaliplatin in CRC via SOX2/USP7/HIF-1α signaling axis (66). The gene discussed is SOX2; the disease is colorectal carcinoma.